The “value” of immune-checkpoint inhibitors for advanced lung cancer

Research output: Contribution to journal › Editorial

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{684d64c027734dcc8af69220ef06526c,

title = "The “value” of immune-checkpoint inhibitors for advanced lung cancer",

author = "Akira Inoue",

year = "2017",

month = jul,

doi = "10.1016/j.resinv.2017.04.001",

language = "English",

volume = "55",

pages = "253--254",

journal = "Respiratory Investigation",

issn = "2212-5345",

publisher = "Elsevier BV",

number = "4",

}

TY - JOUR

T1 - The “value” of immune-checkpoint inhibitors for advanced lung cancer

AU - Inoue, Akira

PY - 2017/7

Y1 - 2017/7

UR - http://www.scopus.com/inward/record.url?scp=85020123686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020123686&partnerID=8YFLogxK

U2 - 10.1016/j.resinv.2017.04.001

DO - 10.1016/j.resinv.2017.04.001

M3 - Editorial

C2 - 28705302

AN - SCOPUS:85020123686

SN - 2212-5345

VL - 55

SP - 253

EP - 254

JO - Respiratory Investigation

JF - Respiratory Investigation

IS - 4

ER -